The 20 Best Myeloproliferative Neoplasms (MPN) Doctors Near Me in Lake Success, NY

Gerard Donnelly is a Hematologist practicing medicine in New Hyde Park, New York. Dr. Donnelly is rated as a Distinguished provider by MediFind in the treatment of Myeloproliferative Neoplasms (MPN). He is also highly rated in 68 other conditions, according to our data. His clinical expertise encompasses Protein S Deficiency, Congenital Antithrombin 3 Deficiency, Hereditary Resistance to Anti-Vitamin K, and Protein C Deficiency.

Eileen Sheehy-Milano,MD is an attending physician based at the Monter Cancer Center where she has special interests in breast cancer and gastrointestinal cancer. Board certified in Internal Medicine and Medical Oncology, she maintains an active practice where she focuses on compassionate, personalized, evidence based multi-disciplinary care. Prior to moving her practice to the Monter Cancer Center, Dr. Sheehy-Milano practiced for 25 years at Northwell Glen Cove Hospital. She earned her medical degree at the Jefferson College for Health Professions in Philadelphia,Pennsylvania. She trained in Internal Medicine at St. Francis Hospital and Medical Center in Hartford, Connecticut with a chief residency year as part of the U. Conn. health system. She completed a fellowship in Medical Oncology at Baylor College of Medicine in Houston, Texas. An active member of the American Society of Clinical Oncology and the American Medical Association, Dr. Sheehy-Milano is an Assistant Professor of Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. Dr. Milano is rated as an Experienced provider by MediFind in the treatment of Myeloproliferative Neoplasms (MPN). She is also highly rated in 14 other conditions, according to our data. Her clinical expertise encompasses Angiosarcoma, Anemia, Breast Cancer, and Paget Disease of the Breast. Dr. Milano is board certified in American Board Of Internal Medicine/Medical Oncology.

Jonathan Kolitz, MD, FACP, is Professor of Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. An expert in malignant hematology, he is the System Head for Malignant Hematology for the Northwell Health Cancer Institute where he guides the clinical care and research activities of faculty and fellows. Board certified in Internal Medicine, Hematology and Medical Oncology, Dr. Kolitz has been a member of the Leukemia Core Committee of the CALGB/Alliance since 1993. He has focused on the development, conduct and publication of innovative clinical trials for the treatment of hematologic malignancies, especially acute leukemia. He has been principal investigator for numerous novel drug trials and has been involved in multiple national and international collaborations, leading to over 200 publications. As an attending physician at the Monter Cancer Center, Dr. Kolitz focuses on providing compassionate, personalized, evidence-based care. Dr. Kolitz earned his medical degree from the Yale University School of Medicine. He trained in Internal Medicine at North Shore University Hospital and Hematology and Medical Oncology at Memorial Sloan-Kettering Cancer Center. Dr. Kolitz is an active member of the American Society of Hematology, American Society of Clinical Oncology and the American College of Physicians. Dr. Kolitz is rated as an Experienced provider by MediFind in the treatment of Myeloproliferative Neoplasms (MPN). He is also highly rated in 46 other conditions, according to our data. His clinical expertise encompasses Leukemia, Chronic B-Cell Leukemia (CBCL), Acute Myeloid Leukemia (AML), Chronic Lymphocytic Leukemia (CLL), and Bone Marrow Aspiration. Dr. Kolitz is board certified in American Board Of Internal Medicine, American Board Of Internal Medicine/Hematology, and American Board Of Internal Medicine/Medical Oncology.

Steven L. Allen, MD, FACP, is Professor of Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. An expert in benign and malignant hematology, he is the System Head for Benign Hematology for the Northwell Health Cancer Institute. As an attending physician at the Monter Cancer Center, Dr. Allen focuses on providing compassionate, personalized, evidence-based multi-disciplinary care. Board certified in Internal Medicine, Hematology and Medical Oncology, Dr. Allen has been the principal investigator for numerous drug trials and has collaborated with several basic science labs, resulting in over 150 publications. Among his many professional affiliations, he is most active with the American Society of Hematology, having served in numerous leadership positions and committees. In addition, he is a dedicated member of the American Society of Clinical Oncology, Empire State Hematology and Oncology Society, and the American College of Physicians. Dr. Allen earned his medical degree from the Johns Hopkins School of Medicine. He trained in internal medicine and hematology/oncology at New York Hospital-Weill Cornell Medical Center. Dr. Allen is rated as an Experienced provider by MediFind in the treatment of Myeloproliferative Neoplasms (MPN). He is also highly rated in 43 other conditions, according to our data. His clinical expertise encompasses Non-Hodgkin Lymphoma, Monoclonal Gammopathy of Undetermined Significance (MGUS), Schnitzler Syndrome, Follicular Lymphoma, and Bone Marrow Aspiration. Dr. Allen is board certified in American Board Of Internal Medicine, American Board Of Internal Medicine/Hematology, and American Board Of Internal Medicine/Medical Oncology.

Shams Shakil, MD, PhD, MS, is an attending physician based at the Monter Cancer Center where he specializes in the treatment of patients with benign and malignant hematologic conditions. Board certified in Internal Medicine, Hematology and Medical Oncology, Dr. Shakil is an Assistant Professor of Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. Dr. Shakil maintains an active medical practice focusing on compassionate, personalized, evidence-based multi-disciplinary care. He earned his medical degree from Chittagong Medical College in Bangladesh, his PhD from Hiroshima University School of Medicine and his MS in Medical Informatics from the Oregon Health and Science University. His fellowship in Hematology/Oncology was completed at Brookdale University Hospital Center. Dr. Shakil has a research background in both surgical oncology and radiation oncology. He is an active member of the American Society of Hematology. Dr. Shakil is rated as an Experienced provider by MediFind in the treatment of Myeloproliferative Neoplasms (MPN). He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Sickle Cell Disease, Anemia, Large-Cell Immunoblastic Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), and Bone Marrow Aspiration.

Ruthee-lu Bayer is a Transplant Surgeon practicing medicine in Lake Success, New York. Dr. Bayer is rated as an Experienced provider by MediFind in the treatment of Myeloproliferative Neoplasms (MPN). She is also highly rated in 24 other conditions, according to our data. Her clinical expertise encompasses Non-Hodgkin Lymphoma, Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Bayer is board certified in American Board Of Internal Medicine.

Jaime Andres Suarez Londono, MD, MBA, MS, is the associate director of the adult transplantation and cellular therapy program at Northwell Cancer Institute. After completing medical school in Medellin, Colombia, Dr. Londono did a residency at Columbia University's St Luke's Roosevelt Hospital and a fellowship at Albert Einstein College of Medicine. He then spent eight years as an assistant professor at NYU Langone's Perlmutter Cancer Center, where he held several leadership roles in the NYU Grossman Long Island School of Medicine, and in the stem cell transplant programI was inspired to study hematology, oncology and transplantation because advances in the field are bringing new hope and transforming the lives of our patients in a positive way, says Dr. Londono, who believes that the future of cancer treatment lies in personalized medicine approaches, such as immunotherapy and genetic therapy.Dr. Londono joined Northwell Cancer Institute to continue his research on improving outcomes and expanding access to life saving stem cell transplants and cellular therapies. My goal is to advance the field so we can overcome the challenges of limited donor compatibility and patient eligibility, ensuring more people benefit from transformative treatments, he says.Dr. Londono and his team have authored more than a dozen scientific papers, and his current work is gaining international recognition. Beyond research, he is passionate about public outreach through the American Society of Hematology, serving as co- director of the of Health Volunteers Overseas LATAM. He was honored with the Golden Apple Award from the American Society of Hematology's Health Volunteers Overseas program in recognition of his contributions to global health.Dr. Londono is the founder of a startup dedicated to alleviating physician shortages in the United States. With an eye toward the future, Dr. Londono recently earned an MBA and an MS in Healthcare Leadership from Cornell University. I wanted to study the global healthcare landscape how medicine is delivered in different countries, what lessons we can learn, and the nuances of biotech companies and market dynamics, he explains.Outside of medicine, Dr. Londono pursues his passion for cuisine by taking classes at the American Culinary Institute. Yet his most rewarding moments come at the bedside. My patients are truly 'patient' often spending three or four weeks in the hospital. It's incredibly inspiring to witness their resilience, commitment, and humility. They are the reason I work so hard. Dr. Londono is rated as an Experienced provider by MediFind in the treatment of Myeloproliferative Neoplasms (MPN). He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Myelodysplastic Syndrome (MDS), Childhood Acute Myeloid Leukemia, Acute Myeloid Leukemia (AML), Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Londono is board certified in American Board Of Internal Medicine/Hematology and American Board Of Internal Medicine/Medical Oncology.

Maria Jacqueline Nieto,MD,MSc is an Assistant Professor of Medicine at The Donald and Barbara Zucker School of Medicine at Hofstra/Northwell where she specializes in treating patients with benign and malignant hematological conditions.Dr Nieto is board certified in Internal Medicine and Medical Oncology. Dr Nieto's clinical focus is on myelodysplastic syndromes, myeloproliferative disorders, and lymphomas. She is particularly interested in the care of the elderly with hematological malignancies, evaluating treatment disparities in cancer care, and optimizing cancer and palliative care at the end of life. She is co-investigator on multiple clinical trials focused on the treatment of patients with hematological malignancies. Dr Nieto has a Master of Science degree in Clinical Research from New York University.Dr Nieto is an active member in the American Society of Clinical Oncology and the American Society of Hematology and is fluent in Spanish. Dr. Nieto is rated as an Experienced provider by MediFind in the treatment of Myeloproliferative Neoplasms (MPN). She is also highly rated in 9 other conditions, according to our data. Her clinical expertise encompasses ALK-Positive Non-Small Cell Lung Cancer, Lung Adenocarcinoma, Small Cell Lung Cancer (SCLC), Bone Marrow Aspiration, and Tissue Biopsy.

Steven R. Savona, MD, is an attending physician based at the Monter Cancer Center where his major clinical interests include blood disorders such as malignant and non-malignant hematology diseases as well as oncology expertise in the areas of diseases of the skin including melanoma, basal cell cancer and squamous cell cancer; he also sees patients with colorectal cancer and pancreas cancer. Dr. Savona maintains an active medical practice focusing on compassionate, personalized, evidence-based multi-disciplinary care. Board certified in Internal Medicine, Medical Oncology, Hematology and Hospice/Palliative medicine, Dr. Savona is an Assistant Professor of Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. Dr. Savona is an active participant in the Cancer Control Program of the National Cancer Institute sponsored clinical trials based at Northwell. He is an investigator on cancer control studies, studies for the treatment of cancer of the pancreas as well as squamous cancer of the skin. In prior studies, Dr. Savona has addressed issues such as tobacco dependency and smoking cessation, redeveloping life styles and physical activity levels after completion of chemotherapy, the prevention of infections in patients with impaired immunity and prevention of hot flashes in patients on hormonal therapy. Dr. Savona earned his medical degree from Duke University School of Medicine. He completed both his residency in internal medicine and his fellowship in Medical Oncology/Hematology at New York University Medical Center. Dr. Savona is an active member of the American Society of Hematology and the American Society of Clinical Oncology. Dr. Savona is rated as an Experienced provider by MediFind in the treatment of Myeloproliferative Neoplasms (MPN). He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Malignant Peripheral Nerve Sheath Tumor, Bone Tumor, Melanoma, Thrombocytopenia, and Bone Marrow Aspiration. Dr. Savona is board certified in American Board Of Internal Medicine, American Board Of Internal Medicine/Hematology, and American Board Of Internal Medicine/Medical Oncology.

Bradley Goldberg, MD, is an attending physician based at the Monter Cancer Center where he specializes in treating patients with both benign and malignant hematologic conditions. Board certified in Internal Medicine, Hematology, and Medical Oncology, Dr. Goldberg maintains an active practice where he focuses on compassionate, personalized, and evidence-based multi-disciplinary care. He is part of the team rotating through the inpatient malignant hematology service at North Shore University Hospital (located on 7 Monti). Dr. Goldberg earned his medical degree at SUNY Downstate College of Medicine. He completed his internal medicine residency and his medical oncology and hematology fellowship at the Northwell Health program located at North Shore University Hospital and Long Island Jewish Medical Center. He is currently an Assistant Professor of Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. He is an active member of the American Society of Hematology and the American Society of Clinical Oncology. Dr. Goldberg is rated as an Experienced provider by MediFind in the treatment of Myeloproliferative Neoplasms (MPN). He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Acute Promyelocytic Leukemia, Childhood Acute Myeloid Leukemia, Acute Myeloblastic Leukemia without Maturation, Acute Myeloblastic Leukemia with Maturation, and Bone Marrow Aspiration. Dr. Goldberg is board certified in American Board Of Internal Medicine, American Board Of Internal Medicine/Hematology, and American Board Of Internal Medicine/Medical Oncology.

Douglas Gladstone is a Transplant Surgeon practicing medicine in Lake Success, New York. Dr. Gladstone is rated as an Experienced provider by MediFind in the treatment of Myeloproliferative Neoplasms (MPN). He is also highly rated in 24 other conditions, according to our data. His clinical expertise encompasses Hairy Cell Leukemia (HCL), Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), Hodgkin Lymphoma, and Bone Marrow Aspiration.

Wayne Tam is a Pathologist and a Medical Genetics provider practicing medicine in New Hyde Park, New York. Dr. Tam is rated as an Experienced provider by MediFind in the treatment of Myeloproliferative Neoplasms (MPN). He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Childhood Acute Myeloid Leukemia, Acute Promyelocytic Leukemia, Prolymphocytic Leukemia, and Chronic Myelogenous Leukemia (CML). Dr. Tam is board certified in American Board Of Pathology and American Board Of Pathology/Anatomic Pathology.

John Mascarenhas is an Oncologist practicing medicine in New York, New York. Dr. Mascarenhas is rated as an Elite provider by MediFind in the treatment of Myeloproliferative Neoplasms (MPN). He is also highly rated in 38 other conditions, according to our data. His clinical expertise encompasses Myelofibrosis, Myeloproliferative Neoplasms (MPN), Polycythemia Vera, Bone Marrow Aspiration, and Splenectomy. Dr. Mascarenhas is currently accepting new patients.

Ronald Hoffman is an Oncologist practicing medicine in New York, New York. Dr. Hoffman is rated as an Elite provider by MediFind in the treatment of Myeloproliferative Neoplasms (MPN). He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Polycythemia Vera, Myelofibrosis, Essential Thrombocythemia, Splenectomy, and Bone Marrow Transplant.

Marina Kremyanskaya is an Oncologist practicing medicine in New York, New York. Dr. Kremyanskaya is rated as an Elite provider by MediFind in the treatment of Myeloproliferative Neoplasms (MPN). She is also highly rated in 31 other conditions, according to our data. Her clinical expertise encompasses Myelofibrosis, Polycythemia Vera, Essential Thrombocythemia, Bone Marrow Aspiration, and Splenectomy. Dr. Kremyanskaya is currently accepting new patients.

Raajit Rampal is a Hematologist and an Oncologist practicing medicine in New York, New York. Dr. Rampal is rated as an Elite provider by MediFind in the treatment of Myeloproliferative Neoplasms (MPN). He is also highly rated in 34 other conditions, according to our data. His clinical expertise encompasses Myeloproliferative Neoplasms (MPN), Myelofibrosis, Essential Thrombocythemia, Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Rampal is currently accepting new patients.

Ross Levine is a Hematologist and an Oncologist practicing medicine in New York, New York. Dr. Levine is rated as an Elite provider by MediFind in the treatment of Myeloproliferative Neoplasms (MPN). He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Myeloproliferative Neoplasms (MPN), Acute Myeloid Leukemia (AML), Leukemia, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Levine is currently accepting new patients.

Malin Hultcrantz is a Hematologist and an Oncologist practicing medicine in New York, New York. Dr. Hultcrantz is rated as an Elite provider by MediFind in the treatment of Myeloproliferative Neoplasms (MPN). She is also highly rated in 9 other conditions, according to our data. Her clinical expertise encompasses Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance (MGUS), Smoldering Multiple Myeloma, Myeloproliferative Neoplasms (MPN), and Bone Marrow Aspiration. Dr. Hultcrantz is currently accepting new patients.

Douglas Tremblay is a Hematologist practicing medicine in New York, New York. Dr. Tremblay is rated as an Elite provider by MediFind in the treatment of Myeloproliferative Neoplasms (MPN). He is also highly rated in 26 other conditions, according to our data. His clinical expertise encompasses Myeloproliferative Neoplasms (MPN), Myelofibrosis, Polycythemia Vera, Bone Marrow Aspiration, and Splenectomy.

Omar Abdel is a Hematologist and an Oncologist practicing medicine in New York, New York. Dr. Abdel is rated as an Elite provider by MediFind in the treatment of Myeloproliferative Neoplasms (MPN). He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Reticulohistiocytoma, Hairy Cell Leukemia (HCL), Leukemia, Rosai-Dorfman Disease, and Bone Marrow Aspiration. Dr. Abdel is currently accepting new patients.